• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌随访骨扫描的疗效

Efficacy of follow-up bone scans in carcinoma of the prostate.

作者信息

Corrie D, Timmons J H, Bauman J M, Thompson I M

机构信息

Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, Texas.

出版信息

Cancer. 1988 Jun 15;61(12):2453-4. doi: 10.1002/1097-0142(19880615)61:12<2453::aid-cncr2820611211>3.0.co;2-p.

DOI:10.1002/1097-0142(19880615)61:12<2453::aid-cncr2820611211>3.0.co;2-p
PMID:3130180
Abstract

Three hundred fifteen radioisotopic bone scans ranging from initial scan only to nine scans per patient, performed on 114 patients with adenocarcinoma of the prostate between 1979 and 1984, were reviewed. Seventeen patients had positive scans, ten on initial scan and seven at follow-up. Nine patients had bone pain at the time of the first positive scan and pain developed in two patients 6 months and 2 years later, respectively. The other six patients are still asymptomatic 1 to 4 years later. False-positive scans were found in six other patients. No patient with bone pain had a negative scan. We believe that routine bone scans for prostate cancer follow-up are not cost-effective unless the patient is symptomatic. Bone scans also are indicated for initial staging and to observe disease response to protocol treatment.

摘要

回顾了1979年至1984年间对114例前列腺腺癌患者进行的315次放射性核素骨扫描,扫描次数从仅进行初次扫描到每位患者进行9次扫描。17例患者扫描结果为阳性,10例初次扫描阳性,7例随访时阳性。9例患者在首次阳性扫描时有骨痛,另外2例患者分别在6个月和2年后出现疼痛。其他6例患者在1至4年后仍无症状。另外6例患者出现假阳性扫描结果。有骨痛的患者扫描结果均无阴性。我们认为,除非患者有症状,否则前列腺癌随访的常规骨扫描不具有成本效益。骨扫描也适用于初始分期以及观察疾病对方案治疗的反应。

相似文献

1
Efficacy of follow-up bone scans in carcinoma of the prostate.前列腺癌随访骨扫描的疗效
Cancer. 1988 Jun 15;61(12):2453-4. doi: 10.1002/1097-0142(19880615)61:12<2453::aid-cncr2820611211>3.0.co;2-p.
2
The role of routine followup bone scans after definitive therapy of localized prostatic cancer.局限性前列腺癌根治性治疗后常规随访骨扫描的作用。
J Urol. 1982 Sep;128(3):510-2. doi: 10.1016/s0022-5347(17)53021-9.
3
The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.转移性前列腺癌放射性核素骨扫描中的闪烁现象。
AJR Am J Roentgenol. 1984 Apr;142(4):773-6. doi: 10.2214/ajr.142.4.773.
4
The benefits of combining early radionuclide renal scintigraphy with routine bone scans in patients with prostate cancer.在前列腺癌患者中联合早期放射性核素肾闪烁扫描与常规骨扫描的益处。
J Urol. 1988 Dec;140(6):1448-51. doi: 10.1016/s0022-5347(17)42070-2.
5
Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.自动化骨扫描指数的分析验证:作为一种成像生物标志物,用于标准化转移性前列腺癌患者骨扫描的定量变化。
J Nucl Med. 2016 Jan;57(1):41-5. doi: 10.2967/jnumed.115.160085. Epub 2015 Aug 27.
6
[Value of bone gammagraphy and pain in the follow-up of carcinoma of the prostate].[骨闪烁显像及疼痛在前列腺癌随访中的价值]
Arch Esp Urol. 1989;42 Suppl 2:206-8.
7
[The role of bone scintigraphy and its value in the staging and follow up of prostatic carcinoma].
Orv Hetil. 1989 Feb 12;130(7):335-40.
8
Evaluation of preoperative ProstaScint scans in the prediction of nodal disease.术前前列腺闪烁扫描在预测淋巴结疾病中的评估。
Prostate Cancer Prostatic Dis. 2002;5(2):132-5. doi: 10.1038/sj.pcan.4500570.
9
Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.根据初始骨扫描的疾病范围对转移性前列腺癌患者进行分层。
Cancer. 1988 Jan 1;61(1):195-202. doi: 10.1002/1097-0142(19880101)61:1<195::aid-cncr2820610133>3.0.co;2-y.
10
Capromab Pendetide imaging of prostate cancer.前列腺癌的癌胚抗原-前列腺特异性膜抗原显像
Cancer Biother Radiopharm. 2000 Apr;15(2):131-40. doi: 10.1089/cbr.2000.15.131.

引用本文的文献

1
Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.血清钙、碱性磷酸酶和血红蛋白作为膀胱癌骨转移的危险因素。
PLoS One. 2017 Sep 13;12(9):e0183835. doi: 10.1371/journal.pone.0183835. eCollection 2017.
2
Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis.血清护骨素和核因子 κB 配体受体激活剂在日本伴有骨转移的前列腺癌患者中的意义。
Int J Clin Oncol. 2011 Aug;16(4):366-72. doi: 10.1007/s10147-011-0193-7. Epub 2011 Feb 16.
3
Imaging in the diagnosis and management of prostate cancer.
前列腺癌诊断与管理中的影像学检查
Rev Urol. 2004 Summer;6(3):101-13.
4
Dynamic quantitative bone scintigraphy in patients with prostatic carcinoma treated by orchiectomy.睾丸切除术后前列腺癌患者的动态定量骨闪烁显像
Eur J Nucl Med. 1990;16(8-10):671-6. doi: 10.1007/BF00998167.